ANA GUTIERREZ: Open Payments
NPI 1922342013 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 27 payments from 8 companies in 2025. Trend: 2023 $434 · 2024 $696 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $430 |
| GlaxoSmithKline, LLC. | 6 | $188 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
| CSL Behring | 1 | $19 |
| GENZYME CORPORATION | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $17 |
Products named: NUCALA, TEZSPIRE, AIRSUPRA, BREZTRI, NEFFY, TRICLIP, FASENRA, Hizentra.
Industry payments across AZ — which companies pay providers there.
